|
|
Application of continuous quality improvement in the management of high risk drugs in obstetrics and gynecology |
CHEN Xue-xia |
The First Division of Department of Obstetrics,Women and Children′s Hospital Affiliated to Xiamen University,Fujian Province,Xiamen 361001,China |
|
|
Abstract Objective To evaluate the application value of continuous quality improvement in the management of highrisk drugs in obstetrics and gynecology.Methods The time before continuous quality improvement was set from February 2016 to February 2017,and the time from March 2017 to March 2018 was set as after improvement.The frequency of high-risk drug management defects before and after continuous quality improvement were recorded.Results The management of high-risk drugs in the gynecology and obstetrics ward was checked for 48 times,with 336 times recorded in total.The total frequency of defects before improvement was 110 times,higher than that after improvement for 16 times,which was statistically significant (P<0.05);after continuous quality improvement,the incidence rates of drugs mixed (0.06%),lack of identification (0.00%),the base number not supplemented in time (1.79%),management not standardized (1.79%),no professional management (0.00%),shift handover not carried out Unscientific (0.00%),poor management risk awareness (0.06%) were lower than before (4.76%,3.57%,5.95%,7.14%,2.38%,2.98%,5.95%),the differences were statistically significant (P<0.05).The awareness of nurses after the improvement was 85.71%,higher than 47.61% after the improvement,and the difference was statistically significant (P<0.05).Conclusion In the management of high-risk drugs in obstetrics and gynecology,the effect of continuous quality improvement is significant,which can improve the safety level of high-risk drug management,enhance the drug safety of patients,and improve the defects of high-risk drug management.
|
|
|
|
|
[1] |
唐守艳,盛夏.基于美国JCI 体系的规范化管理在我院泌尿外科高危药品管理中的应用[J].中国医药导报,2017,14(17):131-133,149.
|
[2] |
陈立瑜,孙莉萍,莫永珍,等.在移动护理系统下高危药品闭环管理的持续质量改进[J].江苏卫生事业管理,2019,30(1):63-65.
|
[3] |
李玉珍,刘庭芳.基于追踪方法学的高危药品管理评审评价体系的应用效果分析[J].中国药房,2017,28(4):521-526.
|
[4] |
阳佩,童宇平,张珊珊.急诊科护士对静脉输注高危药物的认知现状及影响因素分析[J].护理研究,2017,31(17):2146-2148.
|
[5] |
罗秀娟,谢佩珠,程彩萍,等.以专科护士为主导的项目管理在静脉治疗质量控制中的应用效果研究[J].护理管理杂志,2017,17(6):415-417.
|
[6] |
廖全山.追踪方法学在医院高危药品管理持续改进中的应用及可行性研究[J].临床医药文献电子杂志,2018,5(41):182-183.
|
[7] |
符红波,周燕琼,张耀峰,等.应用PDCA 循环管理规范婴幼儿腹腔镜下内环口高位结扎术围手术期抗菌药物的预防使用[J].中国现代药物应用,2017,11(10):4-6.
|
[8] |
Story L,Hutter J,Zhang T,et al.The use of antenatal fetal magnetic resonance imaging in the assessment of patients at high risk of preterm birth[J].Eur J Obstet Gynecol Reprod Biol,2018,222:134-141.
|
[9] |
Carey ET,Moulder JK.Perioperative Management and implementation of enhanced recovery programs in gynecologic surgery for benign indications[J].Obstet Gynecol,2018,132(1):137-146.
|
[10] |
Cumyn A,Sauvé N,Rey E.Atrial fibrillation with a structurally normal heart in pregnancy:An international survey on current practice[J].Obstet Med,2017,10(2):74-78.
|
[11] |
Kalafat E,Sukur YE,Abdi A,et al.Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity:systematic review and metaanalysis of randomized trials[J].Ultrasound Obstet Gynecol,2018,52(6):706-714.
|
[12] |
El-Sayed AAF.Preeclampsia:A review of the pathogenesis and possible management strategies based on its pathophysiological derangements[J].Taiwan J Obstet Gynecol.,2017,56(5):593-598.
|
[13] |
李慧,李华娣,谢巧玲,等.基于JCI 国际标准从高危药品储存管理遵从率探讨高危药品管理效果[J].临床合理用药杂志,2019,12(22):12-13,15.
|
[14] |
邹碧霓,袁爱茵,吴一嫣.老年科高危药品的风险管理[J].解放军医院管理杂志,2019,26(1):98-100.
|
[15] |
刘明珍.持续质量改进在妇产科高危药品管理中的应用[J].世界最新医学信息文摘,2018,18(91):182,193.
|
|
|
|